Therapeutic effects of the putative P2X3/P2X2/3 antagonist A-317491 on cyclophosphamide-induced cystitis in rats

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 377, Issue 4-6, 2008, Pages 483-490

  Ito, Katsuaki ^a   Iwami, Akihito ^a   Katsura, Hiromi ^a   Ikeda, Masahiro ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

A 317391; Bladder; Cyclophosphamide; Cystitis; Cystometry; Oxybutynin; P2X receptor; Urinary frequency

Indexed keywords

5 [[(3 PHENOXYBENZYL)(1,2,3,4 TETRAHYDRO 1 NAPHTHYL)AMINO]CARBONYL]TRIMELLITIC ACID; CYCLOPHOSPHAMIDE; OXYBUTYNIN; PURINERGIC P2X2 RECEPTOR; PURINERGIC P2X3 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BLADDER CONTRACTION; CONFERENCE PAPER; CONTROLLED STUDY; CYSTITIS; CYSTOMETRY; DRUG EFFECT; DRUG MECHANISM; FEMALE; HYPERREFLEXIA; MICTURITION; NONHUMAN; OVERACTIVE BLADDER; RAT; RESIDUAL URINE; URINARY FREQUENCY; URINE VOLUME;

ANIMALS; CYCLOPHOSPHAMIDE; CYSTITIS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INJECTIONS, INTRAVENOUS; MANDELIC ACIDS; PHENOLS; POLYCYCLIC COMPOUNDS; PYRIDOXAL PHOSPHATE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P2; URINARY BLADDER, OVERACTIVE;

EID: 45749129759     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-007-0197-z     Document Type: Conference Paper

References (31)

1. Andersson K-E, Hedlund P (2002) Pharmacologic perspective on the physiology of the lower urinary tract. Urology 60:13-20
2. Angelico P, Velasco C, Guarneri L, Sironi G, Leonardi A, Testa R (2005) Urodynamic effects of oxybutynin and tolterodine in conscious and anesthetized rats under different cystometrographic conditions. BMC Pharmacol 5:14
3. Birder LA, Ruan HZ, Chopra B, Xiang Z, Barrick S, Buffington CA, Roppolo JR, Ford APDW, de Groat WC, Burnstock G (2004) Alterations in P2X and P2Y purinergic receptor expression in urinary bladder from normal cats and cats with interstitial cystitis. Am J Physiol 287:F1084-F1091
4. Borvendeg SJ, Al-Khrasani M, Rubini P, Fischer W, Allgaier C, Wirkner K, Himmel HM, Gillen C, Illes P (2003) Subsensitivity of P2X but not vanilloid 1 receptors in dorsal root ganglia of rats caused by cyclophosphamide cystitis. Eur J Pharmacol 474:71-75
5. Brady CM, Apostolidis A, Yiangou Y, Baecker PA, Ford AP, Freeman A, Jacques TS, Fowler CJAnand P (2004) P2X3-immunoreactive nerve fibres in neurogenic detrusor overactivity and the effect of intravesical resiniferatoxin. Eur Urol 46:247-253
6. Chopra B, Barrick SR, Meyers S, Beckel JM, Zeidel ML, Ford APDW, de Groat WC, Birder LA (2005) Expression and function of bradykinin B1 and B2 receptors in normal and inflamed rat urinary bladder urothelium. J Physiol (Lond) 562:859-871
7. Cockayne DA, Hamilton SG, Zhu Q-M, Dunn PM, Zhong Y, Novakovic S, Malmberg AB, Cain G, Berson A, Kassotakis L, Hedley L, Lachnit WG, Burnstock G, McMahon SB, Ford APDW (2000) Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature 407:1011-1015
8. Cruz F (2004) Mechanisms involved in new therapies for overactive bladder. Urology 63:65-73
9. de Groat WC (2006) Integrative control of the lower urinary tract: preclinical perspective. Br J Pharmacol 147:S25-S40
10. Ford APDW, Gever JR, Nunn PA, Zhong Y, Cefalu JS, Dillon MP, Cockayne DA (2006) Purinoceptors as therapeutic targets for lower urinary tract dysfunction. Br J Pharmacol 147:S132-S143
11. Hedlund P, Streng T, Lee T, Andersson K-E (2007) Effects of tolterodine on afferent neurotransmission in normal and resiniferatoxin treated conscious rats. J Urol 178:326-331
12. Hu VY, Malley S, Dattilio A, Folsom JB, Zvara P, Vizzard MA (2003) COX-2 and prostanoid expression in micturition pathways after cyclophosphamide-induced cystitis in the rat. Am J Physiol 284:R574-R585
13. Jarvis MF, Burgard EC, McGaraughty S, Honore P, Lynch K, Brennan TJ, Subieta A, van Biesen T, Cartmell J, Bianchi B, Niforatos W, Kage K, Yu H, Mikusa J, Wismer CT, Zhu CZ, Chu K, Lee C-H, Stewart AO, Polakowski JS, Cox BF, Kowaluk E, Williams M, Sullivan JP, Faltynek C (2002) A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat. Proc Natl Acad Sci USA 99:17179-17184
14. 3H]A-317491, a novel high-affinity non-nucleotide antagonist that specifically labels human P2X2/3 and P2X3 receptors. J Pharmacol Exp Ther 310:407-416
15. 3 receptor subunits can account for ATP-gated currents in sensory neurons. Nature 377:432-435
16. Million M, Wang L, Stenzel-Poore MP, Coste SC, Yuan PQ, Lamy C, Rivier J, Buffington T, Tache Y (2007) Enhanced pelvic responses to stressors in female CRF-overexpressing mice. Am J Physiol 292:R1429-R1438
17. Modiri A-R, Alberts P, Gillberg P-G (2002) Effect of muscarinic antagonists on micturition pressure measured by cystometry in normal, conscious rats. Urology 59:963-968
18. Nazif O, Teichman JMH, Gebhart GF (2007) Neural upregulation in interstitial cystitis. Urology 69:S24-S33
19. Nishiguchi J, Hayashi Y, Chancellor MB, de Miguel F, de Groat WC, Kumon H, Yoshimura N (2005) Detrusor overactivity induced by intravesical application of adenosine 5′-triphosphate under different delivery conditions in rats. Urology 66:1332-1337
20. Pandita RK, Andersson KE (2002) Intravesical adenosine triphosphate stimulates the micturition reflex in awake, freely moving rats. J Urol 168:1230-1234
21. Pinna C, Sanvito P, Bolego C, Cignarella A, Puglisi L (2005) Effect of the ATP-sensitive potassium channel opener ZM226600 on cystometric parameters in rats with ligature-intact, partial urethral obstruction. Eur J Pharmacol 516:71-77
22. Rapp DE, Lyon MB, Bales GT, Cook SP (2005) A role for the P2X receptor in urinary tract physiology and in the pathophysiology of urinary dysfunction. Eur Urol 48:303-308
23. Rong W, Spyer KM, Burnstock G (2002) Activation and sensitisation of low and high threshold afferent fibres mediated by P2X receptors in the mouse urinary bladder. J Physiol (Lond) 541:591-600
24. Ruggieri MR (2006) Mechanisms of disease: role of purinergic signaling in the pathophysiology of bladder dysfunction. Nature Clin Pract Urol 3:206-215
25. Smith CP, Vemulakonda VM, Kiss S, Boone TB, Somogyi GT (2005) Enhanced ATP release from rat bladder urothelium during chronic bladder inflammation: effect of botulinum toxin A. Neurochem Int 47:291-297
26. 3 receptors. Nature 407:1015-1017
27. Suzuki M, Ohtake A, Yoshino T, Yuyama H, Hayashi A, Ukai M, Okutsu H, Noguchi Y, Sato S, Sasamata M (2005) Effects of solifenacin succinate (YM905) on detrusor overactivity in conscious cerebral infarcted rats. Eur J Pharmacol 512:61-66
28. Tsukimi Y, Mizuyachi K, Matsumoto H, Sato M, Ng B, Tajimi M (2004) Mechanism of action by which aspirin alleviates detrusor hyperactivity in rats. J Pharmacol Sci 95:101-107
29. Wu G, Whiteside GT, Lee G, Nolan S, Niosi M, Pearson MS, Ilyin VI (2004) A-317491, a selective P2X3/P2X2/3 receptor antagonist, reverses inflammatory mechanical hyperalgesia through action at peripheral receptors in rats. Eur J Pharmacol 504:45-53
30. Yoshimura N, de Groat WC (1999) Increased excitability of afferent neurons innervating rat urinary bladder after chronic bladder inflammation. J Neurosci 19:4644-4653
31. Zhong Y, Banning AS, Cockayne DA, Ford APDW, Burnstock G, McMahon SB (2003) Bladder and cutaneous sensory neurons of the rat express different functional P2X receptors. Neuroscience 120:667-675